首页> 外国专利> Nucleotide array from the genome of the retro-virus of HIV-1, HIV-2 and SIV type, and, especially, for amplifying the genome of these retro-viruses and application null of these arrays for in vitro diagnosis of the infection by these

Nucleotide array from the genome of the retro-virus of HIV-1, HIV-2 and SIV type, and, especially, for amplifying the genome of these retro-viruses and application null of these arrays for in vitro diagnosis of the infection by these

机译:来自HIV-1,HIV-2和SIV型逆转录病毒基因组的核苷酸阵列,尤其是用于扩增这些逆转录病毒的基因组,并将这些阵列无效用于体外诊断这些病毒的感染

摘要

Oligonucleotide (I), comprising a specific sequence (A) of the gene gag or gene pol, and susceptible to hybridize at 60[deg]C+-1[deg]C with the genomes of viruses HIV-1 Bru, HIV-1 Mal, HIV-1 Eli, HIV-2 Rod or SIV Mac; or a sequence complementary to a sequence (A), is new. Independent claims are also included for: (1) couple of oligonucleotide primers (II), for carrying out a gene amplification of the gene gag or gene pol of the virus of the type HIV-1 Bru, HIV-1 Mal, HIV-1 Eli, HIV-2 Rod or SIV Ma, where the primers consists each one of: a specific sequence of the gene gag or gene pol, and susceptible to hybridize at 60[deg]C+-1[deg]C with the genomes of viruses HIV-1 Bru, HIV-1 Mal, HIV-1 Eli, HIV-2 Rod or SIV Mac; or a sequence complementary to the sequence (A); (2) a process of gene amplification of nucleic sequences of the gene gag or the gene pol of virus of type (HIV-1 and/or HIV-2, and/or SIV, from a biological sample, comprising: (a) a stage of extraction of the nucleic acid to be detected belonging to the genome of the virus of the HIV-1 type, HIV-2 or SIV, optionally present in the biological sample, and optionally a stage of treatment using a reverse transcriptase of the nucleic acid if the latter is in the form of RNA; (b) a cycle comprising: denaturation of the double stranded nucleic acid to be detected, which leads to the formation of a single strand nucleic acid, hybridization of each strand of nucleic acid, obtained at the stage of denaturation, with at least a primer or a couple of primers of (II), by setting in contact the strands with at least a couple of the primers, formation from primers, of complementary DNA strands on which they are hybridized in the presence of a DNA polymerase and four different nucleosides triphosphate (NTP), which leads to the formation of a greater number of double strand nucleic acid to be detected at the stage of preceding denaturation, and repetition of the cycle for a determined number of times to obtain the nucleic sequence to be detected optionally present in the biological sample in a proportion sufficient to allow its detection; and (c) a stage of detection of the optional presence of the nucleic acid belonging to the genome of the virus in the biological sample; and (3) a kit for carrying out the process of gene amplification of nucleic sequences of the gene gag or the gene pol of virus of type (HIV-1 and/or HIV-2, and/or SIV, from a biological sample, comprising: at least a primer or a couple of oligonucleotidic primers of (II); reagents appropriate to be used in cycle of amplification, in particular DNA polymerase, four different nucleotide triphosphate, and buffer 10X; and one (or several) probe, can be marked, capable of hybridizing with the amplified sequence of nucleic acid to be detected.
机译:寡核苷酸(I),包含基因gag或基因pol的特定序列(A),并易于在60°C + -1°C下与病毒HIV-1 Bru,HIV-1 Mal的基因组杂交,HIV-1 Eli,HIV-2 Rod或SIV Mac;或与序列(A)互补的序列是新的。还包括以下方面的独立权利要求:(1)一对寡核苷酸引物(II),用于对HIV-1 Bru,HIV-1 Mal,HIV-1型病毒的基因gag或基因pol进行基因扩增Eli,HIV-2 Rod或SIV Ma,其中的引物包括以下各项之一:基因gag或基因pol的特定序列,并易于在60°C + -1°C与病毒基因组杂交HIV-1 Bru,HIV-1 Mal,HIV-1 Eli,HIV-2 Rod或SIV Mac;或与序列(A)互补的序列; (2)从生物样品中扩增类型为(HIV-1和/或HIV-2和/或SIV)的病毒的基因gag或基因pol的核酸序列的基因的方法,包括:(a)属于HIV-1型病毒,HIV-2或SIV病毒基因组的待检测核酸的提取阶段,可选地存在于生物样品中,以及可选地,使用核酸的逆转录酶进行治疗的阶段如果后者为RNA形式,则为酸性;(b)包括以下步骤的循环:使待检测的双链核酸变性,从而导致形成单链核酸,获得每条核酸链的杂交在变性阶段,通过使链与至少一对引物接触,该引物与至少一对(II)引物互补,所述互补DNA链在其上杂交,所述引物与至少一对引物接触,由引物形成DNA聚合酶和四个不同核苷三磷酸的存在e(NTP),导致在先前的变性阶段形成更多数量的待检测双链核酸,并重复确定次数的循环以获得任选存在的待检测核酸序列在生物样品中的含量足以使其被检测到; (c)在生物样品中检测属于病毒基因组的核酸的任选存在的阶段; (3)一种试剂盒,用于从生物样品中扩增类型为HIV-1和/或HIV-2和/或SIV的病毒的基因gag或基因pol的核酸序列的基因,包含:至少一个(II)的引物或一对寡核苷酸引物;适用于扩增循环的试剂,特别是DNA聚合酶,四种不同的三磷酸核苷酸和缓冲液10X;以及一个(或几个)探针,可以标记,能够与待检测核酸的扩增序列杂交。

著录项

  • 公开/公告号JPH04507043A

    专利类型

  • 公开/公告日1992-12-10

    原文格式PDF

  • 申请/专利权人 PASTEUR INSTITUT;INST NAT SANTE RECH MED;

    申请/专利号JP19900508911

  • 发明设计人 MONCANY MAURICE;MONTAGNIER LUC;

    申请日1990-06-05

  • 分类号A61K39/00;A61K39/21;A61K48/00;A61P31/18;C07H21/04;C07K14/00;C07K14/155;C07K14/16;C07K16/00;C07K16/10;C12N15/09;C12N15/49;C12Q1/68;C12Q1/70;G01N33/569;

  • 国家 JP

  • 入库时间 2022-08-22 05:13:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号